Helen of Troy Limited (HELE) 10-Q 10 Jul 19 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	May 31, 2019	Jul. 08, 2019
Document and Entity Information
Entity Registrant Name	HELEN OF TROY LTD
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	May 31, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		25,106,551
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	May 31, 2019	Feb. 28, 2019
Assets, current:
Cash and cash equivalents	$ 18,375	$ 11,871
Receivables - principally trade, less allowances of $1,146 and $2,032	262,511	280,280
Inventory	335,344	302,339
Prepaid expenses and other current assets	19,764	10,369
Total assets, current	635,994	604,859
Property and equipment, net of accumulated depreciation of $126,621 and $123,744	130,058	130,338
Goodwill	602,320	602,320
Other intangible assets, net of accumulated amortization of $185,308 and $181,463	287,757	291,526
Operating lease assets	36,136
Deferred tax assets, net	8,937	7,991
Other assets, net of accumulated amortization of $2,138 and $2,115	1,629	12,501
Total assets	1,702,831	1,649,535
Liabilities, current:
Accounts payable, principally trade	139,060	143,560
Accrued expenses and other current liabilities	144,461	165,160
Income taxes payable	3,653	1,427
Long-term debt, current maturities	1,884	1,884
Total liabilities, current	289,058	312,031
Long-term debt, excluding current maturities	319,255	318,900
Lease liabilities, noncurrent	43,651
Deferred tax liabilities, net	7,670	5,748
Other liabilities, noncurrent	7,018	16,219
Total liabilities	666,652	652,898
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 25,100,725 and 24,946,046 shares issued and outstanding	2,510	2,495
Additional paid in capital	249,079	246,585
Accumulated other comprehensive income (loss)	(2,011)	1,191
Retained earnings	786,601	746,366
Total stockholders' equity	1,036,179	996,637
Total liabilities and stockholders' equity	$ 1,702,831	$ 1,649,535

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	May 31, 2019	Feb. 28, 2019
Statement of Financial Position [Abstract]
Receivables - principally trade, allowances (in dollars)	$ 1,146	$ 2,032
Property and equipment, accumulated depreciation (in dollars)	126,621	123,744
Other intangible assets, accumulated amortization (in dollars)	185,308	181,463
Other assets, accumulated amortization (in dollars)	$ 2,138	$ 2,115
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	25,100,725	24,946,046
Common stock, shares outstanding (in shares)	25,100,725	24,946,046

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Income Statement [Abstract]
Sales revenue, net	$ 376,335	$ 354,679
Cost of goods sold	222,608	208,121
Gross profit	153,727	146,558
Selling, general and administrative expense (SG&A)	105,901	101,506
Asset impairment charges	0	0
Restructuring charges	619	1,725
Operating income	47,207	43,327
Nonoperating income, net	132	75
Interest expense	(3,308)	(2,687)
Income before income tax	44,031	40,715
Income tax expense	3,337	2,542
Income from continuing operations	40,694	38,173
Loss from discontinued operations, net of tax	0	(381)
Net income	$ 40,694	$ 37,792
Earnings (loss) per share - basic:
Continuing operations (in dollars per share)	$ 1.63	$ 1.44
Discontinued operations (in dollars per share)	0	(0.01)
Total earnings per share - basic (in dollars per share)	1.63	1.42
Earnings (loss) per share - diluted:
Continuing operations (in dollars per share)	1.61	1.43
Discontinued operations (in dollars per share)	0	(0.01)
Total earnings per share - diluted (in dollars per share)	$ 1.61	$ 1.42
Weighted average shares of common stock used in computing earnings per share:
Basic (in shares)	25,019	26,521
Diluted (in shares)	25,245	26,614

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 40,694	$ 37,792
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	(3,993)	104
Cash flow hedge activity - foreign currency contracts	791	3,333
Other comprehensive income (loss)	(3,202)	3,437
Comprehensive income	$ 37,492	$ 41,229

Condensed Consolidated Statemen

Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2018		26,576,000
Beginning balance at Feb. 28, 2018	$ 1,014,459	$ 2,658	$ 230,676	$ 631	$ 780,494
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	38,173				38,173
Loss from discontinued operations	(381)				(381)
Other comprehensive income (loss), net of tax	3,437			3,437
Exercise of stock options (in shares)		44,000
Exercise of stock options	2,056	$ 4	2,052
Net issuance and settlement of restricted stock (in shares)		137,000
Net issuance and settlement of restricted stock	0	$ 14	(14)
Issuance of common stock related to stock purchase plan (in shares)		17,000
Issuance of common stock related to stock purchase plan	1,335	$ 2	1,333
Common stock repurchased and retired (in shares)		(457,000)
Common stock repurchased and retired	(41,548)	$ (46)	(6,585)		(34,917)
Share-based compensation (in shares)		0
Share-based compensation	6,324		6,324
Ending balance (in shares) at May. 31, 2018		26,317,000
Ending balance at May. 31, 2018	1,023,697	$ 2,629	233,783	4,068	783,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of accounting change	(158)	$ (3)	(3)		(152)
Beginning balance (in shares) at Feb. 28, 2019		24,946,000
Beginning balance at Feb. 28, 2019	996,637	$ 2,495	246,585	1,191	746,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	40,694				40,694
Loss from discontinued operations	0				0
Other comprehensive income (loss), net of tax	$ (3,202)			(3,202)
Exercise of stock options (in shares)	35,397	35,000
Exercise of stock options	$ 1,826	$ 4	1,822
Net issuance and settlement of restricted stock (in shares)		173,000
Net issuance and settlement of restricted stock	0	$ 17	(17)
Issuance of common stock related to stock purchase plan (in shares)		15,000
Issuance of common stock related to stock purchase plan	1,408	$ 1	1,407
Common stock repurchased and retired (in shares)		(68,000)
Common stock repurchased and retired	(8,788)	$ (7)	(8,322)		(459)
Share-based compensation	7,604		7,604
Ending balance (in shares) at May. 31, 2019		25,101,000
Ending balance at May. 31, 2019	$ 1,036,179	$ 2,510	$ 249,079	$ (2,011)	$ 786,601

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Cash provided by operating activities:
Net income	$ 40,694	$ 37,792
Less: Loss from discontinued operations	0	(381)
Income from continuing operations	40,694	38,173
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	7,767	7,982
Amortization of financing costs	255	255
Non-cash operating lease asset amortization	654
Provision for doubtful receivables	54	369
Non-cash share-based compensation	7,604	6,324
Loss on the sale or disposal of property and equipment	0	32
Deferred income taxes and tax credits	1,941	3,098
Changes in operating capital, net of effects of acquisition of businesses:
Receivables	17,715	19,522
Inventories	(33,005)	(4,757)
Prepaid expenses and other current assets	(9,282)	(2,344)
Other assets and liabilities, net	9,138	305
Accounts payable	(4,500)	(3,536)
Accrued expenses and other current liabilities	(22,842)	(35,253)
Accrued income taxes	(517)	(1,259)
Net cash provided by operating activities - continuing operations	15,676	28,911
Net cash used by operating activities - discontinued operations	0	(381)
Net cash provided by operating activities	15,676	28,530
Cash used by investing activities:
Capital and intangible asset expenditures	(3,718)	(4,182)
Proceeds from the sale of property and equipment	0	0
Net cash used by investing activities - continuing operations	(3,718)	(4,182)
Net cash used by investing activities - discontinued operations	0	0
Net cash used by investing activities	(3,718)	(4,182)
Cash used by financing activities:
Proceeds from line of credit	165,300	161,200
Repayment of line of credit	(163,300)	(149,300)
Repayment of long-term debt	(1,900)	(1,900)
Proceeds from share issuances under share-based compensation plans	3,234	3,391
Payments for repurchases of common stock	(8,788)	(41,548)
Net cash used by financing activities - continuing operations	(5,454)	(28,157)
Net cash used by financing activities - discontinued operations	0	0
Net cash used by financing activities	(5,454)	(28,157)
Net decrease in cash and cash equivalents	6,504	(3,809)
Cash and cash equivalents, beginning balance	11,871	20,738
Cash and cash equivalents, ending balance	18,375	16,929
Less: Cash and cash equivalents of discontinued operations, ending balance	0	0
Cash and cash equivalents of continuing operations, ending balance	18,375	$ 16,929
Supplemental non-cash items not included above resulting from the adoption of ASC 842
Initial recognition of lease liabilities	$ 46,931

Basis of Presentation and Relat

Basis of Presentation and Related Information	3 Months Ended
	May 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Related Information	Basis of Presentation and Related Information The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of May 31, 2019 and February 28, 2019 , and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2019 , and our other reports on file with the Securities and Exchange Commission (“SEC”). When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to the "FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to United States (“U.S.”) generally accepted accounting principles. References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Housewares, Health & Home, and Beauty. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage and food containers. The Health & Home segment focuses on health care devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, air purifiers, and insect control devices. Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products. On December 20, 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries to Direct Digital, LLC. The results of the Nutritional Supplements operations have been reported as discontinued operations for all periods presented in the consolidated financial statements. For additional information, see Note 5. All other footnotes present results from continuing operations. On March 11, 2019, we announced a process to explore the divestiture of our Personal Care business, which is a component of our Beauty segment and includes our liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. On May 21, 2019, we announced that, after considering our alternatives, we discontinued the formal sale process and intend to continue to operate the Personal Care business to help fuel our Leadership Brand growth. Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany accounts and transactions are eliminated in consolidation. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates. We have reclassified, combined or separately disclosed certain amounts in the prior years’ condensed consolidated financial statements and accompanying footnotes to conform with the current period’s presentation.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	May 31, 2019
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K for the fiscal year ended February 28, 2019. Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4). In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815) , which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

Revenue Recognition

Revenue Recognition	3 Months Ended
	May 31, 2019
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition We adopted the provisions of ASU 2014-9 in the first quarter of fiscal 2019, and we elected to adopt the standard using the retrospective method. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Our revenue is primarily generated from the sale of non-customized consumer products to customers. Revenue is recognized when control of, and title to, the product sold transfers to the customer. Therefore, the timing and amount of revenue recognized was not materially impacted by the new guidance. The adoption of the guidance did not have a material impact on our consolidated financial statements. The provisions of the new guidance did however impact the classification of certain consideration paid to our customers. We therefore reclassified an immaterial amount of such payments from SG&A to a reduction of net sales revenue for all periods presented. Also, in accordance with the guidance, we reclassified an immaterial amount of estimated sales returns from a reduction of receivables to accrued expenses and other current liabilities for all periods presented. We elected to adopt the guidance using the full retrospective method. We measure revenue as the amount of consideration for which we expect to be entitled, in exchange for transferring goods. Certain customers may receive cash incentives such as customer discounts (including volume or trade discounts), advertising discounts and other customer-related programs, which are accounted for as variable consideration. In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration. In accordance with the guidance, most variable consideration is classified as a reduction to net sales. Sales taxes and other similar taxes are excluded from revenue. We elected to account for shipping and handling activities as a fulfillment cost as permitted by the guidance. We do not have unsatisfied performance obligations since our performance obligations are satisfied at a single point in time.

Leases

Leases	3 Months Ended
	May 31, 2019
Leases [Abstract]
Leases	Leases Adoption of the new lease standard resulted in the recording of lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to unamortized lease incentives and deferred rent recorded in accordance with the previous lease guidance. The new standard did not materially impact our consolidated statements of income or cash flows. The Company primarily has leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We include options to extend or terminate the lease in the lease term for accounting considerations, when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of 1 to 14 years. Lease expense for lease payments is recognized on a straight-line basis over the lease term in a manner similar to previous accounting guidance. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the condensed consolidated statements of income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under the new guidance, operating lease expense recognized in the condensed consolidated statement of income during the three months ended May 31, 2019 was $1.6 million . Short-term lease expense is excluded from this amount and is not material. The non-cash component of lease expense is included as an adjustment to reconcile income from continuing operations to net cash provided by operating activities in the condensed consolidated statement of cash flows. A summary of supplemental lease information is as follows: May 31, 2019 Weighted average remaining lease term (years) 11.02 Weighted average discount rate 6.05 % Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 979 A summary of our estimated lease payments, imputed interest and liabilities are as follows: Fiscal Years Ended (in thousands) 2020 $ 5,120 2021 6,593 2022 6,245 2023 5,121 2024 5,625 Thereafter 38,699 Total future lease payments 67,403 Less: imputed interest (20,472 ) Present value of lease liability $ 46,931 May 31, 2019 Lease liabilities, current (1) $ 3,280 Lease liabilities, noncurrent 43,651 Total lease liability $ 46,931 (1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.

Discontinued Operations

Discontinued Operations	3 Months Ended
	May 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations In December 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries ("Healthy Directions") to Direct Digital, LLC. The purchase price from the sale was comprised of $46.0 million in cash, which was paid at closing, and a supplemental payment with a target value of $25.0 million , payable on or before August 1, 2019. During fiscal 2019, the final amount of the supplemental payment was adjusted to $10.8 million based on a settlement with respect to the calculation of the performance of Healthy Directions through February 28, 2018. The adjustment resulted in a corresponding pre-tax charge of $5.8 million ( $4.4 million after tax) to discontinued operations. Also, during fiscal 2019, we recorded additional net charges of $1.5 million ( $1.3 million after tax) to discontinued operations, resulting from the resolution of certain contingencies. In conjunction with the sale of the business, we have agreed to provide certain transition services that we expect to end in the second quarter of fiscal 2020.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
	May 31, 2019
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information PROPERTY AND EQUIPMENT A summary of property and equipment is as follows: (in thousands) Estimated Useful Lives (Years) May 31, 2019 February 28, 2019 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 113,587 113,820 Computer, software, furniture and other equipment 3 - 15 85,614 84,711 Tools, molds and other production equipment 3 - 7 36,627 36,378 Construction in progress - 8,207 6,529 Property and equipment, gross 256,679 254,082 Less accumulated depreciation (126,621 ) (123,744 ) Property and equipment, net $ 130,058 $ 130,338 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES A summary of accrued expenses and other current liabilities is as follows: (in thousands) May 31, 2019 February 28, 2019 Accrued compensation, benefits and payroll taxes $ 19,502 $ 36,782 Accrued sales discounts and allowances 29,611 28,655 Accrued sales returns 20,793 23,316 Accrued advertising 26,770 26,549 Other 47,785 49,858 Total accrued expenses and other current liabilities $ 144,461 $ 165,160

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	May 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets We perform annual impairment tests each fiscal year during the fourth quarter and interim impairment tests, if and when necessary. We did not record any impairment charges during the first quarters of fiscal 2020 or 2019. The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: May 31, 2019 February 28, 2019 (in thousands) Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 41,481 — (19,885 ) 21,596 41,417 — (19,398 ) 22,019 Subtotal 457,737 — (19,885 ) 437,852 457,673 — (19,398 ) 438,275 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (15,490 ) 1,560 17,050 — (15,402 ) 1,648 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 117,979 — (90,663 ) 27,316 117,967 — (87,953 ) 30,014 Subtotal 481,342 — (106,153 ) 375,189 481,330 — (103,355 ) 377,975 Beauty: Goodwill 81,841 (46,490 ) — 35,351 81,841 (46,490 ) — 35,351 Trademarks - indefinite — — — — 30,407 — — 30,407 Trademarks - finite 30,557 — (566 ) 29,991 150 — (102 ) 48 Licenses - indefinite 10,300 — — 10,300 10,300 — — 10,300 Licenses - finite 13,696 — (12,562 ) 1,134 13,696 — (12,482 ) 1,214 Other intangibles - finite 46,402 — (46,142 ) 260 46,402 — (46,126 ) 276 Subtotal 182,796 (46,490 ) (59,270 ) 77,036 182,796 (46,490 ) (58,710 ) 77,596 Total $ 1,121,875 $ (46,490 ) $ (185,308 ) $ 890,077 $ 1,121,799 $ (46,490 ) $ (181,463 ) $ 893,846 After discontinuing the formal sale process and revising the strategic initiatives for our Personal Care business during the first quarter of fiscal year 2020, we changed trademarks related to the business with a net book value of $30.4 million from indefinite lived to finite lived assets. The amortization of these trademarks is now included in amortization expense for the three months ended May 31, 2019, and these assets are expected to be fully amortized by the end of fiscal year 2027. The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025: Aggregate Amortization Expense For the three months ended (in thousands) May 31, 2019 $ 3,876 May 31, 2018 4,121 Estimated Amortization Expense (in thousands) Fiscal 2020 $ 17,919 Fiscal 2021 16,151 Fiscal 2022 8,550 Fiscal 2023 8,254 Fiscal 2024 7,946 Fiscal 2025 6,896

Share-Based Compensation Plans

Share-Based Compensation Plans	3 Months Ended
	May 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation Plans	Share-Based Compensation Plans We have equity awards outstanding under several share-based compensation plans. During the three months ended May 31, 2019 , we had the following share-based compensation activity: • We issued 1,256 shares to non-employee Board members with a total grant date fair value of $0.1 million and an average share price of $111.80 . • We granted time-vested restricted stock units ("RSUs") that may be settled for 3,271 shares of common stock with a weighted average grant price of $111.41 per share for a total award fair value at date of grant of $0.4 million. • We granted time-vested restricted stock awards ("RSAs") that may be vested for 40,852 shares of common stock with a weighted average grant price of $110.98 per share and a total award fair value at date of grant of $4.5 million. • We granted performance-based stock units ("PSUs") that may be settled for 6,088 shares of common stock with a weighted average grant price of $110.85 per share and a total award fair value at date of grant of $0.7 million. • We granted performance-based restricted stock awards ("PSA's) that are targeted to be vested for 122,402 shares of common stock with a weighted average grant price of $110.85 per share and a total award fair value at date of grant of $13.6 million. • RSUs for 62,840 shares vested and settled, with a total fair value at settlement of $7.1 million, and an average share price of $112.83 per share. • PSUs for 108,572 shares vested and settled with a total grant date fair value of $14.7 million, and an average share price of $135.85 per share. • Employees exercised stock options to purchase 35,397 shares of common stock. • Employees purchased 14,790 shares of common stock under the employee stock purchases plan at an average price of $95.29 per share. We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended May 31, (in thousands, except per share data) 2019 2018 Stock options $ 116 $ 308 Directors stock compensation 140 123 Performance based and other stock awards 7,023 5,571 Employee stock purchase plan 325 322 Share-based compensation expense 7,604 6,324 Less income tax benefits (577 ) (270 ) Share-based compensation expense, net of income tax benefits $ 7,027 $ 6,054 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.28 $ 0.23 Diluted $ 0.28 $ 0.23

Repurchases of Helen of Troy Co

Repurchases of Helen of Troy Common Stock	3 Months Ended
	May 31, 2019
Equity [Abstract]
Repurchase of Helen of Troy Common Stock	Repurchase of Helen of Troy Common Stock On May 20, 2019, we announced that our Board of Directors had authorized the repurchase of up to $400 million of our outstanding common stock. The authorization is effective May 8, 2019, for a period of three years , and replaced Helen of Troy’s previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. As of May 31, 2019 , our repurchase authorization allowed for the purchase of $394.4 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended May 31, (in thousands, except share and per share data) 2019 2018 Common stock repurchased on the open market: Number of shares — 407,025 Aggregate value of shares $ — $ 37,067 Average price per share $ — $ 91.07 Common stock received in connection with share-based compensation: Number of shares 68,204 49,595 Aggregate value of shares $ 8,788 $ 4,481 Average price per share $ 128.85 $ 90.36

Restructuring Plan

Restructuring Plan	3 Months Ended
	May 31, 2019
Restructuring and Related Activities [Abstract]
Restructuring Plan	Restructuring Plan In October 2017, we announced that we had approved a restructuring plan (referred to as “Project Refuel”). Project Refuel includes a reduction-in-force and the elimination of certain contracts and operating expenses. We are targeting total annualized profit improvements of approximately $8.0 to $10.0 million over the duration of the plan. We estimate the plan will be completed during fiscal 2020, and expect to incur total restructuring charges of approximately $7 .0 million over the duration of the plan. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically. For the three months ended May 31, 2019 , we incurred $0.6 million of pre-tax restructuring costs related to employee severance and termination benefits. Since implementing Project Refuel, we have incurred $6.0 million of pre-tax restructuring costs related to employee severance and termination benefits and contract termination costs as of May 31, 2019 . For the three months ended May 31, 2019 , we made total cash restructuring payments of $0.7 million and had a remaining liability of $1.2 million . Since implementing Project Refuel, we have made total cash restructuring payments of $4.9 million as of May 31, 2019 .

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	May 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Matters – On May 31, 2018, we settled a patent infringement dispute related to two forehead thermometer models sold by our subsidiary, Kaz USA, Inc., in the United States and made a settlement payment of $15.0 million , which was accrued in prior periods along with related legal fees and other costs. We are involved in various other legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity. Lease Commitments – The implementation of the new lease guidance (ASC 842) using the effective date method requires the disclosure of our lease commitments from our latest annual report on Form 10-K for the interim periods during the first year of adoption (see Note 4). The lease commitments as of February 28, 2019 were as follows: Fiscal Years Ended the Last Day of February: 2020 2021 2022 2023 2024 After (in thousands) Total 1 year 2 years 3 years 4 years 5 years 5 years Operating leases $ 69,482 $ 5,171 $ 6,678 $ 6,411 $ 5,743 $ 5,078 $ 40,401 The minimum rental payments for operating leases presented above were determined in accordance with the previous lease guidance (ASC 840). The minimum lease payments as of May 31, 2019 , as disclosed in Note 4, are determined in accordance with the new lease guidance (ASC 842).

Long-Term Debt

Long-Term Debt	3 Months Ended
	May 31, 2019
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1.0 billion as of May 31, 2019 . The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods (based upon a base rate or LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment fees and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of May 31, 2019 , the outstanding revolving loan principal balance was $303.2 million (excluding prepaid financing fees) and the face amount of outstanding letters of credit was $9.0 million . For the three months ended May 31, 2019 , borrowings under the Credit Agreement incurred interest expense at rates ranging from 3.4% to 5.5% . For the three months ended May 31, 2018 , borrowings under the Credit Agreement incurred interest expense at rates ranging from 2.8% to 5.0% . As of May 31, 2019 , the amount available for borrowings under the Credit Agreement was $687.8 million . Covenants in our debt agreements limit the amount of total indebtedness we can incur. As of May 31, 2019 , these covenants effectively limited our ability to incur more than $565.8 million of additional debt from all sources, including our Credit Agreement, or $687.8 million in the event a qualified acquisition is consummated. The following table summarizes our long-term debt as of the end of the periods shown: LONG-TERM DEBT (in thousands) Original Date Borrowed Interest Rates Matures May 31, 2019 February 28, 2019 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 20,439 $ 22,335 Credit Agreement (2) 01/15 Floating 12/21 300,700 298,449 Total long-term debt 321,139 320,784 Less current maturities of long-term debt (1,884 ) (1,884 ) Long-term debt, excluding current maturities $ 319,255 $ 318,900 (1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0% , or a Base Rate plus a margin of up to 1.0% , as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement. Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps. At May 31, 2019 and February 28, 2019 , our long-term debt has floating interest rates, and its book value approximates its fair value. All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including a maximum leverage ratio and a minimum interest coverage ratio (as each of these terms is defined in the agreements). Our debt agreements also contain other customary covenants. We were in compliance with the terms of these agreements as of May 31, 2019 .

Fair Value

Fair Value	3 Months Ended
	May 31, 2019
Fair Value Disclosures [Abstract]
Fair Value	Fair Value We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels: Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Assets and liabilities subject to classification are classified upon acquisition. When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred. The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values at May 31, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 1,069 Interest rate swaps — Foreign currency contracts 2,644 Total assets $ 3,713 Liabilities: Floating rate debt $ 321,139 Interest rate swaps 5,027 Foreign currency contracts 17 Total liabilities $ 326,183 Fair Values at February 28, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 915 Interest rate swaps 512 Foreign currency contracts 1,692 Total assets $ 3,119 Liabilities: Floating rate debt $ 320,784 Interest rate swaps 339 Foreign currency contracts 563 Total liabilities $ 321,686 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items. We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps. See Notes 12 and 14 to these condensed consolidated financial statements for more information on our hedging activities. We classify our floating rate debt as a Level 2 item because the estimation of the fair market value requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms. Such comparable rates are considered significant other observable market inputs. The book value of the floating rate debt approximates its fair value as of the reporting date. Our other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 items. These assets are measured at fair value on a non-recurring basis as part of our impairment testing. Note 7 to these condensed consolidated financial statements contains additional information related to intangible asset impairments.

Financial Instruments and Risk

Financial Instruments and Risk Management	3 Months Ended
	May 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During the three months ended May 31, 2019 and 2018 , approximately 12% and 13% of our net sales revenue was denominated in foreign currency, respectively. These sales were primarily denominated in Euros, British Pounds, Canadian Dollars and Mexican Pesos. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases. In our condensed consolidated statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A. We recorded net exchange gains (losses) from foreign currency fluctuations, including the impact of currency hedges and the cross-currency debt swap, of $0.8 million and $(1.7) million in SG&A during the three months ended May 31, 2019 and 2018 , respectively. We hedge against certain foreign currency exchange rate-risk by using a series of forward contracts and zero-cost collars designated as cash flow hedges and mark-to-market derivatives to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. The effective portion of the changes in fair value of these instruments is reported in OCI and reclassified into SG&A in the same period they are settled. The ineffective portion, which is not material for any year presented, is immediately recognized in SG&A. Interest Rate Risk - Interest on our outstanding debt as of May 31, 2019 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225.0 million of the outstanding principal balance under the Credit Agreement, which totaled $303.2 million (excluding prepaid finance fees) as of May 31, 2019 . The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) May 31, 2019 Derivatives designated as hedging instruments Hedge Type Final Settlement Date Notional Amount Prepaid Expenses and Other Current Assets Other Assets Accrued Expenses and Other Current Liabilities Other Liabilities, Non-current Zero-cost collar - Euro Cash flow 2/2020 € 9,500 $ 105 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 1/2020 € 13,500 907 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 2/2020 $ 12,000 282 — — — Zero-cost collar - Pounds Cash flow 2/2020 £ 4,500 52 — — — Foreign currency contracts - sell Pounds Cash flow 11/2020 £ 13,250 797 110 — — Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 20,000 — — 17 — Interest rate swaps Cash flow 1/2024 $ 225,000 — — 997 4,030 Subtotal 2,143 110 1,014 4,030 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 04/2020 € 5,280 331 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 60 — — — Subtotal 391 — — — Total fair value $ 2,534 $ 110 $ 1,014 $ 4,030 (in thousands) February 28, 2019 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2020 € 9,500 $ 11 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 01/2020 € 29,000 1,047 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 02/2020 $ 16,000 168 — — — Zero-cost collar - Pounds Cash flow 05/2020 £ 4,500 — — 200 — Foreign currency contracts - sell Pounds Cash flow 05/2020 £ 19,500 248 — — 13 Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 30,000 — — 58 — Interest rate swaps Cash flow 01/2024 $ 225,000 512 — — 339 Subtotal 1,986 — 258 352 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 04/2020 € 5,280 — 218 — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 — — — 292 Subtotal — 218 — 292 Total fair value $ 1,986 $ 218 $ 258 $ 644 (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The pre-tax effect of derivative instruments for the periods shown is as follows: Three Months Ended May 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (186 ) $ 4,576 SG&A $ (1,218 ) $ 687 $ — $ — Interest rate swaps - cash flow hedges (5,200 ) (61 ) Interest expense — — Interest expense 154 75 Cross-currency debt swaps - principal — — — — SG&A 464 423 Cross-currency debt swaps - interest — — — — Interest Expense 74 74 Total $ (5,386 ) $ 4,515 $ (1,218 ) $ 687 $ 692 $ 572 We expect pre-tax net gains of $1.1 million associated with foreign currency contracts and interest rate swaps currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. Counterparty Credit Risk - Financial instruments, including foreign currency contracts and cross currency debt swaps, expose us to counterparty credit risk for nonperformance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	May 31, 2019
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown: (in thousands) Interest Rate Swaps Foreign Currency Contracts Total Balance at February 28, 2018 $ 1,705 $ (1,074 ) $ 631 Other comprehensive income (loss) before reclassification (61 ) 4,576 4,515 Amounts reclassified out of accumulated other comprehensive income — (687 ) (687 ) Tax effects 165 (556 ) (391 ) Other comprehensive income (loss) 104 3,333 3,437 Balance at May 31, 2018 $ 1,809 $ 2,259 $ 4,068 Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive income (loss) before reclassification (5,200 ) (186 ) (5,386 ) Amounts reclassified out of accumulated other comprehensive income — 1,218 1,218 Tax effects 1,207 (241 ) 966 Other comprehensive income (loss) (3,993 ) 791 (3,202 ) Balance at May 31, 2019 $ (3,861 ) $ 1,850 $ (2,011 ) See Notes 12, 13 and 14 to these condensed consolidated financial statements for additional information regarding our hedging activities.

Segment Information

Segment Information	3 Months Ended
	May 31, 2019
Segment Reporting [Abstract]
Segment Information	Segment Information The following tables present segment information included in continuing operations for the periods shown: Three Months Ended May 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 144,942 $ 154,943 $ 76,450 $ 376,335 Restructuring charges 88 — 531 619 Operating income 31,200 15,056 951 47,207 Capital and intangible asset expenditures 2,867 680 171 3,718 Depreciation and amortization 1,613 4,313 1,841 7,767 Three Months Ended May 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 117,303 $ 163,431 $ 73,945 $ 354,679 Restructuring charges 760 358 607 1,725 Operating income 22,183 19,657 1,487 43,327 Capital and intangible asset expenditures 1,654 2,189 339 4,182 Depreciation and amortization 1,484 4,148 2,350 7,982 We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment. We do not allocate nonoperating income and expense, including interest or income taxes, to operating segments.

Income Taxes

Income Taxes	3 Months Ended
	May 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items. For the three months ended May 31, 2019 , income tax expense as a percentage of income before income tax was 7.6% . Income tax expense for the three months ended May 31, 2019 includes a $0.7 million benefit from the recognition of excess tax benefits from share-based compensation settlements, $1.7 million of expense from the remeasurement of deferred taxes due to tax rate changes, and a $2.8 million benefit from the resolution of an uncertain tax position. For the three months ended May 31, 2018 , income tax expense as a percentage of income before income tax was 6.2% . Income tax expense for the three months ended May 31, 2018 includes a $0.3 million benefit from the recognition of excess tax benefits from share-based compensation settlements, and a $0.8 million benefit from the lapse of the statue of limitations related to an uncertain tax position. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates. During fiscal 2017, we received an assessment from a state tax authority, which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure. We believe we have accurately reported our taxable income and are vigorously protesting the assessment through administrative processes with the state. We believe it is unlikely that the outcome of these matters will have a material adverse effect on our consolidated financial position, results of operations, or liquidity. Our Macau subsidiary generates income from the sale of the goods that it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, we believe our Macau subsidiary will become subject to a statutory corporate income tax of approximately 12%. The ultimate impact of this change, if any, on our overall effective tax rate will depend on a variety of factors including our mix of income by jurisdiction, transfer pricing considerations and the specific tax regulations applicable to us when we are no longer under the Macau Offshore regime. It is not practicable for us to determine the potential impact on our financial statements until the tax changes in Macau are fully established and our transfer pricing analysis is complete. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

Earnings per Share

Earnings per Share	3 Months Ended
	May 31, 2019
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock based awards. See Note 8 to these condensed consolidated financial statements for more information regarding stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended May 31, (in thousands) 2019 2018 Weighted average shares outstanding, basic 25,019 26,521 Incremental shares from share-based compensation arrangements 226 93 Weighted average shares outstanding, diluted 25,245 26,614 Antidilutive securities 352 511

New Accounting Pronouncements (

New Accounting Pronouncements (Policies)	3 Months Ended
	May 31, 2019
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements, Policy	Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4). In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815) , which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

Leases (Tables)

Leases (Tables)	3 Months Ended
	May 31, 2019
Leases [Abstract]
Additional Lease Information	A summary of supplemental lease information is as follows: May 31, 2019 Weighted average remaining lease term (years) 11.02 Weighted average discount rate 6.05 % Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 979
Schedule of Operating Lease Maturities	A summary of our estimated lease payments, imputed interest and liabilities are as follows: Fiscal Years Ended (in thousands) 2020 $ 5,120 2021 6,593 2022 6,245 2023 5,121 2024 5,625 Thereafter 38,699 Total future lease payments 67,403 Less: imputed interest (20,472 ) Present value of lease liability $ 46,931
Schedule of Lease Liabilities	May 31, 2019 Lease liabilities, current (1) $ 3,280 Lease liabilities, noncurrent 43,651 Total lease liability $ 46,931 (1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	3 Months Ended
	May 31, 2019
Balance Sheet Related Disclosures [Abstract]
Schedule of property and equipment	PROPERTY AND EQUIPMENT A summary of property and equipment is as follows: (in thousands) Estimated Useful Lives (Years) May 31, 2019 February 28, 2019 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 113,587 113,820 Computer, software, furniture and other equipment 3 - 15 85,614 84,711 Tools, molds and other production equipment 3 - 7 36,627 36,378 Construction in progress - 8,207 6,529 Property and equipment, gross 256,679 254,082 Less accumulated depreciation (126,621 ) (123,744 ) Property and equipment, net $ 130,058 $ 130,338
Schedule of accrued expenses and other current liabilities	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES A summary of accrued expenses and other current liabilities is as follows: (in thousands) May 31, 2019 February 28, 2019 Accrued compensation, benefits and payroll taxes $ 19,502 $ 36,782 Accrued sales discounts and allowances 29,611 28,655 Accrued sales returns 20,793 23,316 Accrued advertising 26,770 26,549 Other 47,785 49,858 Total accrued expenses and other current liabilities $ 144,461 $ 165,160

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	May 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of carrying amounts and associated accumulated amortization for all intangible assets by operating segment	The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: May 31, 2019 February 28, 2019 (in thousands) Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 41,481 — (19,885 ) 21,596 41,417 — (19,398 ) 22,019 Subtotal 457,737 — (19,885 ) 437,852 457,673 — (19,398 ) 438,275 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (15,490 ) 1,560 17,050 — (15,402 ) 1,648 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 117,979 — (90,663 ) 27,316 117,967 — (87,953 ) 30,014 Subtotal 481,342 — (106,153 ) 375,189 481,330 — (103,355 ) 377,975 Beauty: Goodwill 81,841 (46,490 ) — 35,351 81,841 (46,490 ) — 35,351 Trademarks - indefinite — — — — 30,407 — — 30,407 Trademarks - finite 30,557 — (566 ) 29,991 150 — (102 ) 48 Licenses - indefinite 10,300 — — 10,300 10,300 — — 10,300 Licenses - finite 13,696 — (12,562 ) 1,134 13,696 — (12,482 ) 1,214 Other intangibles - finite 46,402 — (46,142 ) 260 46,402 — (46,126 ) 276 Subtotal 182,796 (46,490 ) (59,270 ) 77,036 182,796 (46,490 ) (58,710 ) 77,596 Total $ 1,121,875 $ (46,490 ) $ (185,308 ) $ 890,077 $ 1,121,799 $ (46,490 ) $ (181,463 ) $ 893,846
Summary of amortization expense attributable to intangible assets	The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025: Aggregate Amortization Expense For the three months ended (in thousands) May 31, 2019 $ 3,876 May 31, 2018 4,121
Schedule of estimated amortization expense of intangible assets	Estimated Amortization Expense (in thousands) Fiscal 2020 $ 17,919 Fiscal 2021 16,151 Fiscal 2022 8,550 Fiscal 2023 8,254 Fiscal 2024 7,946 Fiscal 2025 6,896

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	3 Months Ended
	May 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based compensation expense in SG&A	We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended May 31, (in thousands, except per share data) 2019 2018 Stock options $ 116 $ 308 Directors stock compensation 140 123 Performance based and other stock awards 7,023 5,571 Employee stock purchase plan 325 322 Share-based compensation expense 7,604 6,324 Less income tax benefits (577 ) (270 ) Share-based compensation expense, net of income tax benefits $ 7,027 $ 6,054 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.28 $ 0.23 Diluted $ 0.28 $ 0.23

Repurchase of Helen of Troy Com

Repurchase of Helen of Troy Common Stock (Tables)	3 Months Ended
	May 31, 2019
Equity [Abstract]
Summary of share repurchase activity	The following table summarizes our share repurchase activity for the periods shown: Three Months Ended May 31, (in thousands, except share and per share data) 2019 2018 Common stock repurchased on the open market: Number of shares — 407,025 Aggregate value of shares $ — $ 37,067 Average price per share $ — $ 91.07 Common stock received in connection with share-based compensation: Number of shares 68,204 49,595 Aggregate value of shares $ 8,788 $ 4,481 Average price per share $ 128.85 $ 90.36

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	May 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Contractual Obligations and Commercial Commitments	The lease commitments as of February 28, 2019 were as follows: Fiscal Years Ended the Last Day of February: 2020 2021 2022 2023 2024 After (in thousands) Total 1 year 2 years 3 years 4 years 5 years 5 years Operating leases $ 69,482 $ 5,171 $ 6,678 $ 6,411 $ 5,743 $ 5,078 $ 40,401

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
	May 31, 2019
Debt Disclosure [Abstract]
Summary of long-term debt	The following table summarizes our long-term debt as of the end of the periods shown: LONG-TERM DEBT (in thousands) Original Date Borrowed Interest Rates Matures May 31, 2019 February 28, 2019 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 20,439 $ 22,335 Credit Agreement (2) 01/15 Floating 12/21 300,700 298,449 Total long-term debt 321,139 320,784 Less current maturities of long-term debt (1,884 ) (1,884 ) Long-term debt, excluding current maturities $ 319,255 $ 318,900 (1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0% , or a Base Rate plus a margin of up to 1.0% , as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement. Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps.

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	May 31, 2019
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy of financial assets and liabilities presented at fair value and measured on a recurring basis	The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values at May 31, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 1,069 Interest rate swaps — Foreign currency contracts 2,644 Total assets $ 3,713 Liabilities: Floating rate debt $ 321,139 Interest rate swaps 5,027 Foreign currency contracts 17 Total liabilities $ 326,183 Fair Values at February 28, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 915 Interest rate swaps 512 Foreign currency contracts 1,692 Total assets $ 3,119 Liabilities: Floating rate debt $ 320,784 Interest rate swaps 339 Foreign currency contracts 563 Total liabilities $ 321,686 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	3 Months Ended
	May 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Schedule of fair values of derivative instruments	The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) May 31, 2019 Derivatives designated as hedging instruments Hedge Type Final Settlement Date Notional Amount Prepaid Expenses and Other Current Assets Other Assets Accrued Expenses and Other Current Liabilities Other Liabilities, Non-current Zero-cost collar - Euro Cash flow 2/2020 € 9,500 $ 105 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 1/2020 € 13,500 907 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 2/2020 $ 12,000 282 — — — Zero-cost collar - Pounds Cash flow 2/2020 £ 4,500 52 — — — Foreign currency contracts - sell Pounds Cash flow 11/2020 £ 13,250 797 110 — — Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 20,000 — — 17 — Interest rate swaps Cash flow 1/2024 $ 225,000 — — 997 4,030 Subtotal 2,143 110 1,014 4,030 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 04/2020 € 5,280 331 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 60 — — — Subtotal 391 — — — Total fair value $ 2,534 $ 110 $ 1,014 $ 4,030 (in thousands) February 28, 2019 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost collar - Euro Cash flow 02/2020 € 9,500 $ 11 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 01/2020 € 29,000 1,047 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 02/2020 $ 16,000 168 — — — Zero-cost collar - Pounds Cash flow 05/2020 £ 4,500 — — 200 — Foreign currency contracts - sell Pounds Cash flow 05/2020 £ 19,500 248 — — 13 Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 30,000 — — 58 — Interest rate swaps Cash flow 01/2024 $ 225,000 512 — — 339 Subtotal 1,986 — 258 352 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swap - Euro (1) 04/2020 € 5,280 — 218 — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 — — — 292 Subtotal — 218 — 292 Total fair value $ 1,986 $ 218 $ 258 $ 644 (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements.
Schedule of pre-tax effect of derivative instruments	The pre-tax effect of derivative instruments for the periods shown is as follows: Three Months Ended May 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (186 ) $ 4,576 SG&A $ (1,218 ) $ 687 $ — $ — Interest rate swaps - cash flow hedges (5,200 ) (61 ) Interest expense — — Interest expense 154 75 Cross-currency debt swaps - principal — — — — SG&A 464 423 Cross-currency debt swaps - interest — — — — Interest Expense 74 74 Total $ (5,386 ) $ 4,515 $ (1,218 ) $ 687 $ 692 $ 572

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	May 31, 2019
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown: (in thousands) Interest Rate Swaps Foreign Currency Contracts Total Balance at February 28, 2018 $ 1,705 $ (1,074 ) $ 631 Other comprehensive income (loss) before reclassification (61 ) 4,576 4,515 Amounts reclassified out of accumulated other comprehensive income — (687 ) (687 ) Tax effects 165 (556 ) (391 ) Other comprehensive income (loss) 104 3,333 3,437 Balance at May 31, 2018 $ 1,809 $ 2,259 $ 4,068 Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive income (loss) before reclassification (5,200 ) (186 ) (5,386 ) Amounts reclassified out of accumulated other comprehensive income — 1,218 1,218 Tax effects 1,207 (241 ) 966 Other comprehensive income (loss) (3,993 ) 791 (3,202 ) Balance at May 31, 2019 $ (3,861 ) $ 1,850 $ (2,011 )

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	May 31, 2019
Segment Reporting [Abstract]
Schedule of segment information	The following tables present segment information included in continuing operations for the periods shown: Three Months Ended May 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 144,942 $ 154,943 $ 76,450 $ 376,335 Restructuring charges 88 — 531 619 Operating income 31,200 15,056 951 47,207 Capital and intangible asset expenditures 2,867 680 171 3,718 Depreciation and amortization 1,613 4,313 1,841 7,767 Three Months Ended May 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 117,303 $ 163,431 $ 73,945 $ 354,679 Restructuring charges 760 358 607 1,725 Operating income 22,183 19,657 1,487 43,327 Capital and intangible asset expenditures 1,654 2,189 339 4,182 Depreciation and amortization 1,484 4,148 2,350 7,982

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
	May 31, 2019
Earnings Per Share [Abstract]
Schedule of components of basic and diluted shares	The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended May 31, (in thousands) 2019 2018 Weighted average shares outstanding, basic 25,019 26,521 Incremental shares from share-based compensation arrangements 226 93 Weighted average shares outstanding, diluted 25,245 26,614 Antidilutive securities 352 511

Basis of Presentation and Rel_2

Basis of Presentation and Related Information (Details)	3 Months Ended
	May 31, 2019Segment$ / shares	Feb. 28, 2019$ / shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common shares, par value (in dollars per share) | $ / shares	$ 0.10	$ 0.10
Number of segments | Segment	3

New Accounting Pronouncements A

New Accounting Pronouncements Adopted Accounting Pronouncements (Details) - USD ($) $ in Thousands	May 31, 2019	Mar. 01, 2019
Accounting Changes and Error Corrections [Abstract]
Lease assets	$ 36,136
Present value of lease liability	$ 46,931	$ 47,223

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	Mar. 01, 2019
Lessee, Lease, Description [Line Items]
Lease assets	$ 36,136
Present value of lease liability	46,931	$ 47,223
Operating lease expense	$ 1,600
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms	14 years
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Lease assets		37,100
Present value of lease liability		$ 47,200

Leases - Additional Lease Infor

Leases - Additional Lease Information (Details) $ in Thousands	3 Months Ended
	May 31, 2019USD ($)
Leases [Abstract]
Weighted average remaining lease term (years)	11 years 7 days
Weighted average discount rate	6.05%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 979

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	May 31, 2019	Mar. 01, 2019
Leases [Abstract]
2020	$ 5,120
2021	6,593
2022	6,245
2023	5,121
2024	5,625
Thereafter	38,699
Total future lease payments	67,403
Less: imputed interest	(20,472)
Present value of lease liability	$ 46,931	$ 47,223

Leases - Schedule of Lease Liab

Leases - Schedule of Lease Liabilities (Details) - USD ($) $ in Thousands	May 31, 2019	Mar. 01, 2019
Leases [Abstract]
Lease liabilities, current	$ 3,280
Lease liabilities, noncurrent	43,651
Total lease liability	$ 46,931	$ 47,223

Discontinued Operation (Details

Discontinued Operation (Details) - Discontinued Operations - Healthy Directions LLC - USD ($) $ in Millions	12 Months Ended
	Feb. 28, 2019	Dec. 31, 2017
Discontinued Operations
Purchase price from sale		$ 46
Supplemental payment with a target value	$ 10.8	$ 25
Reduction of supplemental payment	5.8
Reduction of supplemental payment after tax	4.4
Resolution of certain contingencies	1.5
Resolution of certain contingencies, after tax	$ 1.3

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	Feb. 28, 2019
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 256,679	$ 254,082
Less accumulated depreciation	(126,621)	(123,744)
Property and equipment, net	130,058	130,338
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	12,644	12,644
Building and improvements
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 113,587	113,820
Building and improvements | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Building and improvements | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	40 years
Computer, furniture and other equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 85,614	84,711
Computer, furniture and other equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Computer, furniture and other equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	15 years
Tools, dies, molds and other production equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 36,627	36,378
Tools, dies, molds and other production equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Tools, dies, molds and other production equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	7 years
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 8,207	$ 6,529

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information - Liabilities (Details) - USD ($) $ in Thousands	May 31, 2019	Feb. 28, 2019
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 19,502	$ 36,782
Accrued sales discounts and allowances	29,611	28,655
Accrued sales returns	20,793	23,316
Accrued advertising	26,770	26,549
Other	47,785	49,858
Total accrued expenses and other current liabilities	$ 144,461	$ 165,160

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018	Feb. 28, 2019
Changes in Goodwill
Cumulative Goodwill Impairments	$ (46,490)		$ (46,490)
Net Book Value	602,320		602,320
Changes in intangible assets - finite-lived
Accumulated Amortization	(185,308)		(181,463)
Goodwill and intangible assets
Gross Carrying Amount	1,121,875		1,121,799
Net Book Value	890,077		893,846
Indefinite-lived Intangible Assets, Period Increase (Decrease)	30,400
Aggregate Amortization Expense	3,876	$ 4,121
Estimated Amortization Expense
Fiscal 2020	17,919
Fiscal 2021	16,151
Fiscal 2022	8,550
Fiscal 2023	8,254
Fiscal 2024	7,946
Fiscal 2025	6,896
Trademarks
Changes in intangible assets - finite-lived
Net Book Value	29,991
Housewares
Changes in Goodwill
Gross Carrying Amount	282,056		282,056
Net Book Value	282,056		282,056
Changes in intangible assets - finite-lived
Accumulated Amortization	(19,885)		(19,398)
Goodwill and intangible assets
Gross Carrying Amount	457,737		457,673
Net Book Value	437,852		438,275
Housewares | Other intangible assets
Changes in intangible assets - finite-lived
Gross Carrying Amount	41,481		41,417
Accumulated Amortization	(19,885)		(19,398)
Net Book Value	21,596		22,019
Housewares | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	134,200		134,200
Health and Home
Changes in Goodwill
Gross Carrying Amount	284,913		284,913
Net Book Value	284,913		284,913
Changes in intangible assets - finite-lived
Accumulated Amortization	(106,153)		(103,355)
Goodwill and intangible assets
Gross Carrying Amount	481,342		481,330
Net Book Value	375,189		377,975
Health and Home | Licenses
Changes in intangible assets - finite-lived
Gross Carrying Amount	17,050		17,050
Accumulated Amortization	(15,490)		(15,402)
Net Book Value	1,560		1,648
Health and Home | Other intangible assets
Changes in intangible assets - finite-lived
Gross Carrying Amount	117,979		117,967
Accumulated Amortization	(90,663)		(87,953)
Net Book Value	27,316		30,014
Health and Home | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	54,000		54,000
Health and Home | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	7,400		7,400
Beauty
Changes in Goodwill
Gross Carrying Amount	81,841		81,841
Cumulative Goodwill Impairments	(46,490)		(46,490)
Net Book Value	35,351		35,351
Changes in intangible assets - finite-lived
Accumulated Amortization	(59,270)		(58,710)
Goodwill and intangible assets
Gross Carrying Amount	182,796		182,796
Net Book Value	77,036		77,596
Beauty | Trademarks
Changes in intangible assets - finite-lived
Gross Carrying Amount	30,557		150
Accumulated Amortization	(566)		(102)
Net Book Value	30,400		48
Beauty | Licenses
Changes in intangible assets - finite-lived
Gross Carrying Amount	13,696		13,696
Accumulated Amortization	(12,562)		(12,482)
Net Book Value	1,134		1,214
Beauty | Other intangible assets
Changes in intangible assets - finite-lived
Gross Carrying Amount	46,402		46,402
Accumulated Amortization	(46,142)		(46,126)
Net Book Value	260		276
Beauty | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	0		30,407
Beauty | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	$ 10,300		$ 10,300

Share-Based Compensation Plan_2

Share-Based Compensation Plans Narrative (Details) $ / shares in Units, $ in Millions	3 Months Ended
	May 31, 2019USD ($)$ / sharesshares
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Exercise of stock options (in shares)	35,397
Shares purchased under ESPP (in shares)	14,790
Average price of shares purchased (in dollars per share) | $ / shares	$ 95.29
Restricted Stock Units (RSU)
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Number of awards granted (in shares)	3,271
Grant date fair value of RSUs settled in period (in dollars per share) | $ / shares	$ 112.83
Grant date fair value | $	$ 7.1
Shares vested in the period (in shares)	62,840
Shares settled in period (in shares)	62,840
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 111.41
Restricted Stock Units (RSU) | Time-Vested
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Grant date fair value | $	$ 0.4
Restricted Stock
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Number of awards granted (in shares)	40,852
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 110.98
Restricted Stock | Time-Vested
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Grant date fair value | $	$ 4.5
Performance Restricted Stock Units (PSU)
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Number of awards granted (in shares)	6,088
Grant date fair value | $	$ 0.7
Shares vested in the period (in shares)	108,572
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 110.85
Performance Restricted Stock Units (PSU) | Vested and settled performance shares
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Grant date fair value | $	$ 14.7
Shares settled in period (in shares)	108,572
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 135.85
Performance Based Restricted Stock Awards
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Number of awards granted (in shares)	122,402
Grant date fair value of RSUs settled in period (in dollars per share) | $ / shares	$ 110.85
Grant date fair value | $	$ 13.6
Directors
Schedule of Shared-based Compensation Arrangements by Share Based Payment Awards, Activity [Line Items]
Number of awards granted (in shares)	1,256
Grant date fair value | $	$ 0.1
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 111.80

Share-Based Compensation Plan_3

Share-Based Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense, net of income tax benefits	$ 7,027	$ 6,054
Impact of share-based compensation on earnings per share from continuing operations:
Basic (in dollars per share)	$ 0.28	$ 0.23
Diluted (in dollars per share)	$ 0.28	$ 0.23
SG&A
SHARE-BASED PAYMENT EXPENSE
Share-based compensation expense	$ 7,604	$ 6,324
Less income tax benefits	(577)	(270)
SG&A | Directors
SHARE-BASED PAYMENT EXPENSE
Share-based compensation expense	140	123
SG&A | Employee stock options
SHARE-BASED PAYMENT EXPENSE
Share-based compensation expense	116	308
SG&A | Performance Based And Other Stock Awards
SHARE-BASED PAYMENT EXPENSE
Share-based compensation expense	7,023	5,571
SG&A | Employee stock purchase plan
SHARE-BASED PAYMENT EXPENSE
Share-based compensation expense	$ 325	$ 322

Repurchase of Helen of Troy C_2

Repurchase of Helen of Troy Common Stock (Details) - USD ($)	May 20, 2019	May 31, 2019	May 31, 2018
Repurchase of common stock
Amount of shares authorized for purchase	$ 400,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount - prior program	$ 107,400,000
Stock Repurchased During Period, Value		$ 394,400,000
Repurchase of common stock
Aggregate value of shares (in USD)		$ 8,788,000	$ 41,548,000
Open market or tender offer
Repurchase of common stock
Number of shares (in shares)		0	407,025,000
Aggregate value of shares (in USD)		$ 0	$ 37,067,000
Average price per share (in dollars per share)		$ 0	$ 91.07
Stock Compensation Plan
Repurchase of common stock
Number of shares (in shares)		68,204,000	49,595,000
Aggregate value of shares (in USD)		$ 8,788,000	$ 4,481,000
Average price per share (in dollars per share)		$ 128.85	$ 90.36

Restructuring Plan (Details)

Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	May 31, 2019	May 31, 2018	Feb. 29, 2020
Restructuring Plan
Restructuring charges	$ 619	$ 1,725
Project Refuel
Restructuring Plan
Restructuring charges	600
Incurred pre-tax restructuring costs	6,000
Total cash restructuring payments	700
Restructuring Reserve	1,200
Cash restructuring payments since implementation	4,900
Minimum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement	8,000
Maximum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement	$ 10,000
Scenario, Forecast | Project Refuel
Restructuring Plan
Restructuring charges			$ 7,000

Commitments and Contingencies_2

Commitments and Contingencies (Details) $ in Millions	May 31, 2018USD ($)
Thermometer Patent Litigation | Settled Litigation
Commitments and contingencies
Settlement payment	$ 15

Commitments and Contingencies C

Commitments and Contingencies Contractual Obligations (Details) - Operating leases $ in Thousands	May 31, 2019USD ($)
Other Commitments [Line Items]
Total contractual obligations	$ 69,482
2020	5,171
2021	6,678
2022	6,411
2023	5,743
2024	5,078
After 5 years	$ 40,401

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details)	3 Months Ended
	May 31, 2019USD ($)method	May 31, 2018
Minimum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	3.40%	2.80%
Maximum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	5.50%	5.00%
Credit agreement
Long-term debt
Maximum revolving commitment	$ 1,000,000,000
Number of alternative methods under which interest on borrowings accrue | method	2
Amount available for borrowings	$ 687,800,000
Maximum amount of additional debt that can be incurred under debt covenants	565,800,000
Revolving loan | Credit agreement
Long-term debt
Amount outstanding	303,200,000
Letter of credit | Credit agreement
Long-term debt
Amount outstanding	$ 9,000,000

Long-Term Debt - Schedule of Lo

Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($)	3 Months Ended
	May 31, 2019	Feb. 28, 2019
Long-term Debt, by Current and Noncurrent [Abstract]
Long-term debt	$ 321,139,000	$ 320,784,000
Less current maturities of long-term debt	(1,884,000)	(1,884,000)
Long-term debt, excluding current maturities	319,255,000	318,900,000
MBFC Loan
Long-term Debt, by Current and Noncurrent [Abstract]
Long-term debt	20,439,000	22,335,000
Face amount	37,600,000
Maturities of Long-term Debt [Abstract]
Outstanding principal payment on March 1, 2020	1,900,000
Outstanding principal payment on March 1, 2021	1,900,000
Outstanding principal payment on March 1, 2022	1,900,000
Outstanding principal payment on March 1, 2023	$ 14,800,000
MBFC Loan | London Interbank Offered Rate (LIBOR) | Maximum
Long-term Debt, by Current and Noncurrent [Abstract]
Margin (as a percent)	2.00%
MBFC Loan | Base Rate
Long-term Debt, by Current and Noncurrent [Abstract]
Margin (as a percent)	1.00%
Credit agreement
Long-term Debt, by Current and Noncurrent [Abstract]
Long-term debt	$ 300,700,000	$ 298,449,000
Maturities of Long-term Debt [Abstract]
Principal amount hedged	$ 225,000,000

Fair Value (Details)

Fair Value (Details) - Recurring - Fair Values - Significant other observable market inputs (Level 2) - USD ($) $ in Thousands	May 31, 2019	Feb. 28, 2019
Assets:
Total assets	$ 3,713	$ 3,119
Liabilities:
Total liabilities	326,183	321,686
Interest rate swap
Assets:
Derivative assets	0	512
Liabilities:
Derivative liabilities	5,027	339
Foreign currency contracts
Assets:
Derivative assets	2,644	1,692
Liabilities:
Derivative liabilities	17	563
Floating rate debt
Liabilities:
Floating rate debt	321,139	320,784
Money market accounts
Assets:
Money market accounts	$ 1,069	$ 915

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2019	May 31, 2018
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ 0.8	$ (1.7)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	12.00%	13.00%

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Interest Rate Risk (Details) - Credit agreement $ in Millions	May 31, 2019USD ($)
Financial instruments and risk management
Fixed rate debt	$ 225
Floating rate debt	$ 303.2

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	May 31, 2019EUR (€)	May 31, 2019MXN ($)	May 31, 2019USD ($)	May 31, 2019GBP (£)	May 31, 2019CAD ($)	Feb. 28, 2019EUR (€)	Feb. 28, 2019MXN ($)	Feb. 28, 2019USD ($)	Feb. 28, 2019GBP (£)	Feb. 28, 2019CAD ($)
Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			$ 2,534					$ 1,986
Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			110					218
Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			1,014					258
Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			4,030					644
Derivatives designated as hedging instruments | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			2,143					1,986
Derivatives designated as hedging instruments | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			110					0
Derivatives designated as hedging instruments | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			1,014					258
Derivatives designated as hedging instruments | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			4,030					352
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			105					11
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount	€ 9,500			£ 4,500		€ 9,500			£ 4,500
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			52					0
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					200
Derivatives designated as hedging instruments | Zero-cost dollar contract | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €	€ 13,500					29,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			907					1,047
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional amount					$ 12,000					$ 16,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			282					168
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £				13,250					19,500
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			797					248
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			110					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					13
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos
Fair values of derivative instruments in the consolidated balance sheet
Notional amount		$ 20,000					$ 30,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			17					58
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional amount			225,000					225,000
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					512
Derivatives designated as hedging instruments | Interest rate swaps | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives designated as hedging instruments | Interest rate swaps | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			997					0
Derivatives designated as hedging instruments | Interest rate swaps | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			4,030					339
Derivatives not designated under hedge accounting | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			391					0
Derivatives not designated under hedge accounting | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					218
Derivatives not designated under hedge accounting | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives not designated under hedge accounting | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					292
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount			5,280			€ 5,280
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			331					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					218
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £				£ 6,395					£ 6,395
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			60					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets			0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			0					0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities			$ 0					$ 292

Financial Instruments and Ris_6

Financial Instruments and Risk Management - Derivative tax effect (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Pre-tax effect of derivative instruments
Gain/ (loss) recognized in OCI (effective portion)		$ 4,515
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ (1,218)
Gain/ (loss) reclassified from accumulated other comprehensive income (loss) into income		687
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	692
Gain/ (loss) recognized as income		572
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(5,386)
Foreign currency contracts
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(186)
Foreign currency contracts | SG&A
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(1,218)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	0
Gain/ (loss) recognized as income		0
Foreign currency contracts | Cash flow hedges
Pre-tax effect of derivative instruments
Gain/ (loss) recognized in OCI (effective portion)		4,576
Net gain currently reported in accumulated other comprehensive income, to be reclassified into income	$ 1,100
Net gain currently reported in accumulated other comprehensive income, to be reclassified into income, period of time to transfer	12 months
Foreign currency contracts | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain/ (loss) reclassified from accumulated other comprehensive income (loss) into income		687
Interest rate swaps
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	$ (5,200)
Interest rate swaps | Interest expense
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	154
Gain/ (loss) recognized as income		75
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain/ (loss) recognized in OCI (effective portion)		(61)
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain/ (loss) reclassified from accumulated other comprehensive income (loss) into income		0
Cross currency debt swaps
Pre-tax effect of derivative instruments
Gain/ (loss) recognized in OCI (effective portion)		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	0
Gain/ (loss) reclassified from accumulated other comprehensive income (loss) into income		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	0
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	0
Gain/ (loss) reclassified from accumulated other comprehensive income (loss) into income		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	464
Gain/ (loss) recognized as income		423
Cross currency debt swaps | Interest expense
Pre-tax effect of derivative instruments
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	$ 74
Gain/ (loss) recognized as income		$ 74

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 996,637	$ 1,014,459
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss)	(3,202)	3,437
Ending balance	1,036,179	1,023,697
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	132	1,705
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss) before reclassification	(5,200)	(61)
Amounts reclassified out of accumulated other comprehensive income	0	0
Tax effects	1,207	165
Other comprehensive income (loss)	(3,993)	104
Ending balance	(3,861)	1,809
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	1,059	(1,074)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss) before reclassification	(186)	4,576
Amounts reclassified out of accumulated other comprehensive income	1,218	(687)
Tax effects	(241)	(556)
Other comprehensive income (loss)	791	3,333
Ending balance	1,850	2,259
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	1,191	631
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss) before reclassification	(5,386)	4,515
Amounts reclassified out of accumulated other comprehensive income	1,218	(687)
Tax effects	966	(391)
Other comprehensive income (loss)	(3,202)	3,437
Ending balance	$ (2,011)	$ 4,068

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Segment information
Sales revenue, net	$ 376,335	$ 354,679
Restructuring charges	619	1,725
Operating income	47,207	43,327
Capital and intangible asset expenditures	3,718	4,182
Depreciation and amortization	7,767	7,982
Housewares
Segment information
Sales revenue, net	144,942	117,303
Restructuring charges	88	760
Operating income	31,200	22,183
Capital and intangible asset expenditures	2,867	1,654
Depreciation and amortization	1,613	1,484
Health and Home
Segment information
Sales revenue, net	154,943	163,431
Restructuring charges	0	358
Operating income	15,056	19,657
Capital and intangible asset expenditures	680	2,189
Depreciation and amortization	4,313	4,148
Beauty
Segment information
Sales revenue, net	76,450	73,945
Restructuring charges	531	607
Operating income	951	1,487
Capital and intangible asset expenditures	171	339
Depreciation and amortization	$ 1,841	$ 2,350

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2019	May 31, 2018
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations		$ 0.8
Income tax expense (benefit) as a percent of income before income taxes	7.60%	6.20%
Tax benefit recorded related to the recognition of excess tax benefits from share-based compensation	$ 0.7	$ 0.3
Expense for remeasurement of deferred taxes	1.7
Unrecognized tax benefit from favorable resolution of uncertain tax position	$ 2.8

Earnings per Share (Details)

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended
	May 31, 2019	May 31, 2018
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	25,019	26,521
Incremental shares from share-based payment arrangements (in shares)	226	93
Weighted average shares outstanding, diluted (in shares)	25,245	26,614
Employee stock options
Weighted average diluted securities
Antidilutive securities (in shares)	352	511

Uncategorized Items - hele-2019

Label	Element	Value
Non-Cash Increase (Decrease) In Other Current Assets And Liabilities, Net	hele_NonCashIncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	$ (7,311,000)
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37,082,000
Non-cash increase (decrease) in prepaid expense and other assets	hele_Noncashincreasedecreaseinprepaidexpenseandotherassets	43,000
Non-Cash Increase (Decrease) In Other Accrued Liabilities	hele_NonCashIncreaseDecreaseInOtherAccruedLiabilities	$ (2,873,000)